NCT06669091

Food-effect Study of Ecopipam Pharmacokinetics

A Phase 1, Randomized, 2-way Crossover, Food-effect Study of Ecopipam Pharmacokinetics After Administration of the to Be Marketed Tablet in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Emalex Biosciences Inc. · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Standard food-effect study to identify the effect of food on ecopipam pharmacokinetics after administration of a to-be-marketed ecopipam tablet in healthy volunteers.

Conditions

• Food-effect

Interventions

Type	Name	Description
DRUG	Ecopipam tablet	A single ecopipam 89.6 mg tablet (equivalent to ecopipam HCl 100 mg)

Timeline

• Start date: 2024-11-05
• Primary completion: 2024-12-22
• Completion: 2024-12-27
• First posted: 2024-11-01
• Last updated: 2025-01-27

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study